Veterans Forced the VA to Back Down on Disability Ratings. That Fight Is Far from Over.

On 17 February 2026, the Department of Veterans Affairs quietly published an interim final rule in the Federal Register titled “Evaluative Rating: Impact of Medication.” It took effect immediately, with no advance notice and no public comment period. The rule required VA medical examiners to factor in how well a veteran functions on medication when calculating disability ratings. In practice, that meant a veteran whose PTSD symptoms improved with prescribed treatment could see their rating dropped, and their monthly compensation along with it.

The backlash was immediate and bipartisan. Within two days, more than 10,000 comments poured into the Federal Register’s public comment portal. Veterans of Foreign Wars, Disabled American Veterans, and Paralyzed Veterans of America all condemned the change. A federal lawsuit was filed by two law firms representing hundreds of disabled veterans. And Democratic candidates with military backgrounds jumped on the issue, framing it as the latest evidence that the Trump administration’s DOGE-era cost-cutting at the VA puts veterans’ health and financial security at risk.

By 19 February, VA Secretary Doug Collins posted on X that enforcement was halted. By 26 February, the VA filed a formal rescission notice in the Federal Register. The whole episode lasted nine days. But the political damage will linger much longer.

The VA’s disability compensation system assigns ratings on a scale up to 100%, based on how severely a service-connected condition limits a veteran’s ability to function and earn a living. Higher ratings mean higher monthly payments. For decades, the standard practice has been to rate disabilities based on the underlying condition itself. If you lost mobility in your knee during deployment, your rating reflected that injury regardless of whether anti-inflammatory medication helped manage the pain.

A series of court decisions, most recently Ingram v. Collins in 2025, reinforced this principle. Those rulings held that the VA couldn’t reduce ratings simply because medication improved symptoms. Secretary Collins described these decisions as requiring examiners to make assessments based on hypothetical, untreated conditions. He called that standard “unquantifiable” and “unwarranted.”

So the VA pushed out a rule that flipped the approach. Under the new framework, examiners would evaluate a veteran’s “actual level of functional impairment” while on medication. If treatment reduced symptoms, the lower impairment level would determine the rating. The VA framed this as formalizing a practice dating back to 1958. Veterans groups saw it differently. They called it a backdoor benefits cut worth an estimated $23 billion.

The substance was bad enough. But the process made it worse. The VA issued the rule as an “interim final rule” with immediate effect, skipping the standard notice-and-comment rulemaking process that normally gives stakeholders a chance to weigh in before changes take effect. Major veterans service organizations, including the VFW and DAV, were blindsided. The National Association of County Veterans Service Officers said there had been zero communication.

Andrew Tangen, president of the county veterans service officers association, spelled out the real-world consequences. Consider a veteran rated at 100% permanent total disability for PTSD with suicidal ideation and multiple past suicide attempts. If medication improved their symptoms, that veteran could theoretically be re-evaluated at 30%. That’s the difference between full benefits and a fraction of them.

The perverse incentive problem was obvious to everyone except, apparently, the people who wrote the rule. Veterans facing re-evaluation would have reason to stop taking their medication before a compensation exam. For someone managing PTSD, depression, or chronic pain, that’s not just financially motivated gaming. It’s genuinely dangerous.

Paralyzed Veterans of America raised another disturbing scenario. Under the rule’s logic, a veteran with a spinal cord injury who uses a wheelchair to get around could be considered less disabled because the wheelchair improves their mobility. The medication didn’t cure anything. The underlying condition remained. But the rating, and the paycheck, would shrink.

Army combat veteran Kristofer Goldsmith put the mental health dimension in stark terms. For some veterans, he told CNN, suffering the full effects of PTSD feels worth it compared to putting their family at a financial disadvantage. When the choice is between treatment compliance and keeping the lights on, some will choose to suffer.

This is where the 2026 electoral picture comes into sharp focus. Within hours of the rule’s publication, Hell Cat Rebecca Bennett, the former Navy helicopter pilot running for Congress in New Jersey’s 7th District, posted a video on X calling the rule “insane.” She said veterans had already contacted her saying they planned to stop taking their medication out of fear for their ratings. Her framing was direct and effective: if you’re diagnosed with cancer and getting chemotherapy, you still have cancer.

Senator Tammy Duckworth, the combat-wounded Army veteran from Illinois, went after Collins personally. After the enforcement halt, she accused him of backtracking only because veterans called out the administration. Her response on X didn’t mince words. If Collins took veterans’ concerns seriously, she argued, he’d rescind the rule entirely rather than just pause it.

That’s exactly what happened a week later. But the political utility of the episode goes well beyond a single rescinded regulation. For Veteran Democrat candidates running in competitive districts, this fight provided a concrete, emotionally resonant example of what they’ve been arguing all cycle: that their military service gives them unique standing to protect veterans from Washington’s worst impulses.

Secretary Collins’ handling of the crisis deserves its own scrutiny. Before announcing the enforcement halt, he pushed back on criticism by calling it “fake news.” The VA’s official line was that the rule would have “no impact on any veteran’s current disability rating.” But that claim didn’t hold up. While existing ratings may not have been immediately affected, any veteran filing a new claim, seeking an increase, or undergoing a scheduled re-evaluation would have been subject to the new methodology.

The contradiction between Collins’ reassurances and the rule’s plain text eroded trust further. Veterans advocacy groups pointed out that the VA characterized the rule as both an emergency measure requiring immediate implementation and a simple clarification of longstanding practice. It can’t easily be both.

Senator Blumenthal, the ranking Democrat on the Senate Veterans’ Affairs Committee, pressed Collins during a hearing on 29 January. His comprehensive report released the previous week documented 40,000 VA workers lost in the past year, with 88% in healthcare roles. Mental health wait times had ballooned to more than 35 days for new patients. The disability rating rule dropped into an environment where veteran trust in VA leadership was already cratering.

The rescission doesn’t resolve everything. The underlying court case, Ingram v. Collins, continues. The VA has filed an appeal, and whatever the appellate court decides will shape how disability evaluations work going forward. If the courts ultimately rule that the VA must account for medication effects, Congress may need to step in with legislation clarifying the standard.

Blumenthal and his colleagues have already introduced the Putting Veterans First Act, which would require VA reporting on DOGE-related cost decisions and protect veterans from having benefits reduced based on treatment compliance. Whether that legislation advances in a Republican-controlled Senate is another question. But it gives Democratic candidates another talking point: they’re proposing solutions while the other side created the problem.

For the Hell Cats and the broader wave of Veteran Democrats running in 2026, episodes like this are campaign gold. Bennett, Mendoza, Conley, and Sullivan can all speak to this issue with an authority that non-veteran opponents simply don’t have. They didn’t just read about the disability rating system. They’ve navigated it. They know veterans who depend on it. And they were among the first voices demanding the rule be killed.

Step back and the pattern becomes impossible to ignore. The VA attempted to cancel hundreds of contracts through DOGE, including ones supporting cancer treatment registries and the National Center for PTSD. They had to reverse course. The VA proposed slashing 80,000 workers, roughly 15% of the workforce. They scaled that back to 30,000 after public pressure. And now a disability rating rule, published without notice, rescinded within days after veterans organized against it.

Each reversal is being framed as a victory by the VA. Each one is actually an admission that the initial decision was poorly conceived, inadequately reviewed, and implemented without consulting the people it would affect. For Veteran Democrats making the case that military experience translates to better governance, the contrast couldn’t be clearer. They served. They understand the system. And they wouldn’t have let it get this far.

The comment period on the now-rescinded rule technically remains open through 20 April 2026. But the political conversation has already moved on. The question isn’t whether this particular rule will come back. It’s how many more fights like this one will play out before November, and whether voters in swing districts are paying attention.

If the first year of DOGE at the VA is any indication, Veteran Democrats won’t have to look far for their next opportunity to draw the contrast.